Bach2 regulates homeostasis of foxp3+ regulatory t cells and protects against fatal lung disease in mice

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 985-995

  Kim, Eui Ho ^a   Gasper, David J ^a   Lee, Song Hee ^a,b   Plisch, Erin Hemmila ^a   Svaren, John ^c   Suresh, M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN MCL 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACH2 GENE; CELL MATURATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE; HOMEOSTASIS; IMMUNE HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; LUNG DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 TH2 BALANCE;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELLS, CULTURED; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; PULMONARY EOSINOPHILIA; RADIATION CHIMERA; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84893381101     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302378     Document Type: Article

References (44)

1. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
2. Mueller, D. L. 2010. Mechanisms maintaining peripheral tolerance. Nat. Immunol. 11: 21-27.
3. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
4. von Boehmer, H., and F. Melchers. 2010. Checkpoints in lymphocyte development and autoimmune disease. Nat. Immunol. 11: 14-20.
5. Lund, J. M., L. Hsing, T. T. Pham, and A. Y. Rudensky. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320: 1220-1224.
6. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
7. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
8. Campbell, D. J., and M. A. Koch. 2011. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11: 119-130.
9. Wan, Y. Y., and R. A. Flavell. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770.
10. Gavin, M. A., J. P. Rasmussen, J. D. Fontenot, V. Vasta, V. C. Manganiello, J. A. Beavo, and A. Y. Rudensky. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775.
11. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
12. Fu, W., A. Ergun, T. Lu, J. A. Hill, S. Haxhinasto, M. S. Fassett, R. Gazit, S. Adoro, L. Glimcher, S. Chan, et al. 2012. A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells. Nat. Immunol. 13: 972-980.
13. Hill, J. A., M. Feuerer, K. Tash, S. Haxhinasto, J. Perez, R. Melamed, D. Mathis, and C. Benoist. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27: 786-800.
14. Samstein, R. M., A. Arvey, S. Z. Josefowicz, X. Peng, A. Reynolds, R. Sandstrom, S. Neph, P. Sabo, J. M. Kim, W. Liao, et al. 2012. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151: 153-166.
15. Zheng, Y., S. Z. Josefowicz, A. Kas, T. T. Chu, M. A. Gavin, and A. Y. Rudensky. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940.
16. Kallies, A., and S. L. Nutt. 2010. Bach2: plasma-cell differentiation takes a break. EMBO J. 29: 3896-3897.
17. Muto, A., K. Ochiai, Y. Kimura, A. Itoh-Nakadai, K. L. Calame, D. Ikebe, S. Tashiro, and K. Igarashi. 2010. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J. 29: 4048-4061.
18. Muto, A., S. Tashiro, O. Nakajima, H. Hoshino, S. Takahashi, E. Sakoda, D. Ikebe, M. Yamamoto, and K. Igarashi. 2004. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 429: 566-571.
19. Ouyang, W., W. Liao, C. T. Luo, N. Yin, M. Huse, M. V. Kim, M. Peng, P. Chan, Q. Ma, Y. Mo, et al. 2012. Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491: 554-559.
20. Jin, Y., S. A. Birlea, P. R. Fain, T. M. Ferrara, S. Ben, S. L. Riccardi, J. B. Cole, K. Gowan, P. J. Holland, D. C. Bennett, et al. 2012. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat. Genet. 44: 676-680.
21. Dubois, P. C., G. Trynka, L. Franke, K. A. Hunt, J. Romanos, A. Curtotti, A. Zhernakova, G. A. Heap, R. Adány, A. Aromaa, et al. 2010. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 42: 295-302.
22. Plagnol, V., J. M. Howson, D. J. Smyth, N. Walker, J. P. Hafler, C. Wallace, H. Stevens, L. Jackson, M. J. Simmonds, P. J. Bingley, et al; Type 1 Diabetes Genetics Consortium. 2011. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 7: e1002216.
23. Kim, E. H., J. A. Sullivan, E. H. Plisch, M. M. Tejera, A. Jatzek, K. Y. Choi, and M. Suresh. 2012. Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J. Immunol. 188: 4305-4314.
24. Kalia, V., S. Sarkar, S. Subramaniam, W. N. Haining, K. A. Smith, and R. Ahmed. 2010. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32: 91-103.
25. Cretney, E., A. Xin, W. Shi, M. Minnich, F. Masson, M. Miasari, G. T. Belz, G. K. Smyth, M. Busslinger, S. L. Nutt, and A. Kallies. 2011. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12: 304-311.
26. Wang, X., A. L. Szymczak-Workman, D. M. Gravano, C. J. Workman, D. R. Green, and D. A. Vignali. 2012. Preferential control of induced regulatory T cell homeostasis via a Bim/Bcl-2 axis. Cell Death Dis. 3: e270.
27. Pierson, W., B. Cauwe, A. Policheni, S. M. Schlenner, D. Franckaert, J. Berges, S. Humblet-Baron, S. Schonefeldt, M. J. Herold, D. Hildeman, et al. 2013. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3 regulatory T cells. Nat. Immunol. 14: 959-965.
28. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
29. Ouyang, W., O. Beckett, Q. Ma, J. H. Paik, R. A. DePinho, and M. O. Li. 2010. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11: 618-627.
30. Kerdiles, Y. M., E. L. Stone, D. R. Beisner, M. A. McGargill, I. L. Ch'en, C. Stockmann, C. D. Katayama, and S. M. Hedrick. 2010. Foxo transcription factors control regulatory T cell development and function. Published erratum appears in 2011. Immunity 34: 135. Immunity 33: 890-904.
31. Maruyama, T., J. Li, J. P. Vaque, J. E. Konkel, W. Wang, B. Zhang, P. Zhang, B. F. Zamarron, D. Yu, Y. Wu, et al. 2011. Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat. Immunol. 12: 86-95.
32. Nolting, J., C. Daniel, S. Reuter, C. Stuelten, P. Li, H. Sucov, B. G. Kim, J. J. Letterio, K. Kretschmer, H. J. Kim, and H. von Boehmer. 2009. Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J. Exp. Med. 206: 2131-2139.
33. Hill, J. A., J. A. Hall, C. M. Sun, Q. Cai, N. Ghyselinck, P. Chambon, Y. Belkaid, D. Mathis, and C. Benoist. 2008. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29: 758-770.
34. Vu, M. D., X. Xiao, W. Gao, N. Degauque, M. Chen, A. Kroemer, N. Killeen, N. Ishii, and X. C. Li. 2007. OX40 costimulation turns off Foxp3+ Tregs. Blood 110: 2501-2510.
35. So, T., and M. Croft. 2007. Cutting edge: OX40 inhibits TGF-beta-And antigendriven conversion of naive CD4 T cells into CD25+Foxp3+ T cells. J. Immunol. 179: 1427-1430.
36. Zheng, Y., A. Chaudhry, A. Kas, P. deRoos, J. M. Kim, T. T. Chu, L. Corcoran, P. Treuting, U. Klein, and A. Y. Rudensky. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458: 351-356.
37. Beyer, M., Y. Thabet, R. U. Muller, T. Sadlon, S. Classen, K. Lahl, S. Basu, X. Zhou, S. L. Bailey-Bucktrout, W. Krebs, et al. 2011. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat. Immunol. 12: 898-907.
38. Thornton, A. M., P. E. Korty, D. Q. Tran, E. A. Wohlfert, P. E. Murray, Y. Belkaid, and E. M. Shevach. 2010. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184: 3433-3441.
39. Roychoudhuri, R., K. Hirahara, K. Mousavi, D. Clever, C. A. Klebanoff, M. Bonelli, G. Sciume, H. Zare, G. Vahedi, B. Dema, et al. 2013. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 498: 506-510.
40. Van Dyken, S. J., and R. M. Locksley. 2013. Interleukin-4-And interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu. Rev. Immunol. 31: 317-343.
41. Josefowicz, S. Z., R. E. Niec, H. Y. Kim, P. Treuting, T. Chinen, Y. Zheng, D. T. Umetsu, and A. Y. Rudensky. 2012. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482: 395-399.
42. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788.
43. Hoenerhoff, M. J., M. F. Starost, and J. M. Ward. 2006. Eosinophilic crystalline pneumonia as a major cause of death in 129S4/SvJae mice. Vet. Pathol. 43: 682-688.
44. Ward, J. M., M. Yoon, M. R. Anver, D. C. Haines, G. Kudo, F. J. Gonzalez, and S. Kimura. 2001. Hyalinosis and Ym1/Ym2 gene expression in the stomach and respiratory tract of 129S4/SvJae and wild-type and CYP1A2-null B6, 129 mice. Am. J. Pathol. 158: 323-332.